FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

783086004: Dapagliflozin propanediol monohydrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3757375013 Dapagliflozin propanediol monohydrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3757376014 Dapagliflozin propanediol monohydrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5591161000241111 dapagliflozine propanediol monohydraté fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dapagliflozin propanediol monohydrate (substance) Is a Sodium glucose cotransporter subtype 2 inhibitor true Inferred relationship Some
Dapagliflozin propanediol monohydrate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Some
Dapagliflozin propanediol monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dapagliflozin propanediol true Inferred relationship Some
Dapagliflozin propanediol monohydrate (substance) Is a Substance with ether structure true Inferred relationship Some
Dapagliflozin propanediol monohydrate (substance) Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Dapagliflozin propanediol monohydrate (substance) Inferred relationship Some 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Dapagliflozin propanediol monohydrate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start